CJC 1295 with DAC 5mg

CJC 1295 DAC 5mg is a synthetically modified form of Growth Hormone-Releasing Hormone (GHRH) designed to stimulate the secretion of growth hormones from the pituitary gland. This peptide hormone has shown potential to increase serum IGF-1 levels in the bloodstream and may also help treat growth hormone deficiency. The version of CJC-1295 with Drug Affinity Complex (DAC), according to rodent studies, enhances growth hormone production. Consisting of 30 amino acids, this form has an extended half-life of up to 14 days, thanks to the DAC complex.

CJC 1295 DAC 5mg has been proven to have a greater half-life and bioavailability than GHRH. This is due to the addition of a drug affinity complex (DAC) to this peptide’s chain. This binding extends CJC-1295’s half-life, potentially resulting in a prolonged duration of action in several animal species.

https://academic.oup.com/jcem/article/91/3/799/2843281

Important Reminder:
Before reconstitution, ensure both the peptide and bacteriostatic mixing water are at room temperature to support proper dissolution and avoid destabilising the compound.
Bacteriostatic mixing water sold separately.

Disclaimer:

All products featured on this site are intended solely for research purposes and are not for human or animal consumption under any circumstances. These items should not be classified as drugs, foods, cosmetics, or medicinal products. By purchasing, the buyer assumes all associated risks and agrees to handle the products only as specified. Products should be administered by qualified professionals with the relevant expertise.

The distributor, manufacturer, and seller bear no responsibility for any misuse or subsequent outcomes arising from the use of these products. By completing and paying for your order, you agree to our Terms and Conditions and acknowledge that you will abide by these terms.